Enovis Corp (ENOV) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments.

Total Revenue Chart for Enovis Corp

Enovis Corp (ENOV) revenue for FY2025 was USD 2.2B, a 6.7% change from FY2024. Enovis Corp's revenue grew from USD 309.7M in 2004 to USD 2.2B in 2025 (626.0% over 21 years). Earnings per share grew from USD 3.48 in 2018 to USD -0.25 in 2022 (-107.1%). Revenue compound annual growth rate: 5-year CAGR of -6.0%, 10-year CAGR of -5.5%, 20-year CAGR of 9.8%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.